Determinants of leptospirosis in Sri Lanka: Study Protocol

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Agampodi, Suneth B ^a   Nugegoda, Dhanaseela B ^a   Thevanesam, Vasanthi ^b  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; ENDEMIC DISEASE; FEMALE; FEVER; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; LEPTOSPIROSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POWER ANALYSIS; SCREENING TEST; SOCIAL STATUS; SRI LANKA; STRUCTURED QUESTIONNAIRE; CASE CONTROL STUDY; CLINICAL PROTOCOL; METHODOLOGY; QUESTIONNAIRE; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CLINICAL PROTOCOLS; HUMANS; LEPTOSPIROSIS; LOGISTIC MODELS; QUESTIONNAIRES; RESEARCH DESIGN; SRI LANKA;

EID: 78349232818     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-332     Document Type: Article

References (41)

1. WER Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 1999, 74:237-242. WER.
2. Cachay ER, Vinetz JM. A global research agenda for leptospirosis. J Postgrad Med 2005, 51:174-178. 2270399, 16333188.
3. Hartskeerl RA. Leptospirosis: current status and future trends. Indian J Med Microbiol 2006, 24:309. 10.4103/0255-0857.29404, 17185862.
4. Brooks GF, Butel JS, Morse SA. Leptospira and leptospirosis. Medical Microbiology 2004, 338-340. Singapore: MacGrow Hill Education(Asia), 23.
5. Victoriano AF, Smythe LD, Gloriani-Barzaga N, Cavinta LL, Kasai T, Limpakarnjanarat K, Ong BL, Gongal G, Hall J, Coulombe CA, et al. Leptospirosis in the Asia Pacific region. BMC Infect Dis 2009, 9:147. 10.1186/1471-2334-9-147, 2749047, 19732423.
6. Faine S, Adler B, Bolin C, Perolat P. Epidemiology. Leptospira and Leptospirosis 1999, 70. Melbourne: MediSci, 2.
7. Gaynor K, Katz AR, Park SY, Nakata M, Clark TA, Effler PV. Leptospirosis on Oahu: an outbreak associated with flooding of a university campus. Am J Trop Med Hyg 2007, 76:882-885.
8. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003, 3:757-771. 10.1016/S1473-3099(03)00830-2, 14652202.
9. Rajasuriya K, Somasunderam M, Nagaratnam N. Leptospirosis in Ceylon. J Trop Med Hyg 1959, 62:205-210.
10. Epidemiology Unit Leptospirosis. Surveillance Case Definitions for Notifiable Diseases in Sri Lanka 2005, 19-20. Colombo: Epidemiology Unit, Ministry of Health, Epidemiology Unit.
11. Epidemiological Unit Selected notifiable diseases reported by Medical Officers of Health. Weekly Epidemiological Report 2009, 36:4. Epidemiological Unit.
12. Agampodi S, Peacock SJ, Thevanesam V. The potential emergence of leptospirosis in Sri Lanka. Lancet Infect Dis 2009, 9:524-526. 10.1016/S1473-3099(09)70211-7, 19695489.
13. Dassanayake D, Wimalaratna H, Agampodi S, Liyanapathirana V, Piyarathna T, Goonapienuwala B. Evaluation of surveillance case definition in the diagnosis of leptospirosis, using the Microscopic Agglutination Test: a validation study. BMC Infect Dis 2009, 9:48. 10.1186/1471-2334-9-48, 2679753, 19386085.
14. Kularatne SA. Human leptospirosis: Case studies. Zoonotic & Emerging Zoonotic Diseases and their Prevention in the SAARC Region 2008, Faculty of Veterinary Medicine and Animal Science, University of Peradeniya, Sri Lanka.
15. Gunawardhana SA, Sellahewa KH. Clinical features of leptospirosis: a prospective descriptive study at the National Hospital of Sri Lanka (NHSL) in 2007. Ceylon Med J 2008, 53:155-156.
16. Ashford DA, Kaiser RM, Spiegel RA, Perkins BA, Weyant RS, Bragg SL, Plikaytis B, Jarquin C, De Lose Reyes JO, Amador JJ. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 2000, 63:249-254.
17. Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 1999, 28:583-590. 10.1093/ije/28.3.583, 10405868.
18. Everard CO, Bennett S, Edwards CN, Nicholson GD, Hassell TA, Carrington DG, Everard JD. An investigation of some risk factors for severe leptospirosis on Barbados. J Trop Med Hyg 1992, 95:13-22.
19. Johnson MA, Smith H, Joeph P, Gilman RH, Bautista CT, Campos KJ, Cespedes M, Klatsky P, Vidal C, Terry H, et al. Environmental exposure and leptospirosis, Peru. Emerg Infect Dis 2004, 10:1016-1022.
20. Douglin CP, Jordan C, Rock R, Hurley A, Levett PN. Risk factors for severe leptospirosis in the parish of St. Andrew, Barbados. Emerg Infect Dis 1997, 3:78-80. 10.3201/eid0301.970114, 2627591, 9126452.
21. Leal-Castellanos CB, Garcia-Suarez R, Gonzalez-Figueroa E, Fuentes-Allen JL, Escobedo-de la Penal J. Risk factors and the prevalence of leptospirosis infection in a rural community of Chiapas, Mexico. Epidemiol Infect 2003, 131:1149-1156. 10.1017/S0950268803001201, 2870065, 14959783.
22. Nardone A, Capek I, Baranton G, Campese C, Postic D, Vaillant V, Lienard M, Desenclos JC. Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999-2000. Clin Infect Dis 2004, 39:751-753. 10.1086/423272, 15356794.
23. Phraisuwan P, Whitney EA, Tharmaphornpilas P, Guharat S, Thongkamsamut S, Aresagig S, Liangphongphanthu J, Junthima K, Sokampang A, Ashford DA. Leptospirosis: skin wounds and control strategies, Thailand, 1999. Emerg Infect Dis 2002, 8:1455-1459. 2738501, 12498663.
24. Sarkar U, Nascimento SF, Barbosa R, Martins R, Nuevo H, Kalafanos I, Grunstein I, Flannery B, Dias J, Riley LW, et al. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. Am J Trop Med Hyg 2002, 66:605-610.
25. Tangkanakul W, Tharmaphornpil P, Plikaytis BD, Bragg S, Poonsuksombat D, Choomkasien P, Kingnate D, Ashford DA. Risk factors associated with leptospirosis in northeastern Thailand, 1998. Am J Trop Med Hyg 2000, 63:204-208.
26. Leptospirosis-response protocol for NSW public health units. NSW Health 2004,
27. Alberta Health and Wellness DCaP Public Health Notifiable Disease Management Guidelines-Leptospirosis. 2005, Alberta Health and Wellness DCaP.
28. Diseases ZDNIoC Guidelines for Prevention and Control of Leptospirosis. 2006, New Delhi: World Health Organization, Diseases ZDNIoC.
29. World Health Organization and regional medical research centre Report of the Brainstorming Meeting on Leptospirosis Prevention and Control. Mumbai 2006, World Health Organization and regional medical research centre.
30. Washington State Department of Health Leptospirosis. 2002, Washington State Department of Health.
31. Malasia Interim guidelines on leptospirosis. 2006, Malasia.
32. Department of Labour New Zealand Report on "Opportunities for reduction of the incidence and severity of occupationally acquired leptospirosis in New Zealand. Wellington 2007, Department of Labour New Zealand.
33. John TJ. The prevention and control of human leptospirosis. J Postgrad Med 2005, 51:205-209.
34. Case Definitions: Dengue and Leptospirosis. , http://www.paho.org/
35. World Health Organization Human leptospirosis - guidance for diagnosis, surveillance and control. 2003, 1-122. Malta: World Health Organization, World Health Organization.
36. Smythe L. PHLN summary laboratory definition. 2007, WHO/FAO/OIE Collaborating Centre for Reference & Research on Leptospirosis, Western Pacific Region..
37. Lin CH, Hsieh HF, Yu JC, Hsu SD, Chuang CH, Hsieh CB. Education and imaging. Gastrointestinal: Leptospirosis and abdominal pain. J Gastroenterol Hepatol 2006, 21:1755. 10.1111/j.1440-1746.2006.04747.x, 16984604.
38. Victora CG, Huttly S, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol 1997, 26:224-227. 10.1093/ije/26.1.224, 9126524.
39. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol 1992, 135:1029-1041.
40. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992, 135:1042-1050.
41. Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992, 135:1019-1028.